The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Putting the brakes on an enzyme might rescue neurons that are dying in Parkinson's disease, stabilizing the progression of ...

A groundbreaking study suggests that Parkinson’s disease may begin in the kidneys, where a toxic protein builds up and ...

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material responsible for Parkinson's disease from cell to cell in the brain.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.